Home / Portfolios / GLP-1 Revolution
Healthcare / Pharma Speculative

GLP-1 Revolution

GLP-1 Revolution focuses on Companies in the $100B+ weight-loss drug market and metabolic health supply chain.. Starting from a universe of 2882 US equities, the committee applied sector and fundamental quality screens to identify 14 holdings that best align with the speculative mandate. The portfolio emphasizes companies with demonstrated profitability, reasonable valuations, and growth trajectories consistent with the Healthcare / Pharma theme. Position sizing reflects an equal-weight approach with a 5% cash buffer maintained for rebalancing flexibility and commission coverage. The portfolio is designed to be actively managed through Stoquity's factor scoring and committee review process, with holdings subject to ongoing quality, momentum, and risk monitoring.

$100
+0.0% YTD
Follow Portfolio
0.00
Sharpe
0.00
Sortino
1.00
Beta
+0.0%
Alpha
0%
Std Dev
0%
VaR 95%
-12.4%
Max DD
0.00
Treynor

Current Holdings 14 positions

Ticker Company Sector Weight Shares Cost Basis Current P&L
PODD Insulet Healthcare 6.8% 32 $208.22 $208.22 +0.0%
NVO Novo Nordisk Healthcare 6.8% 188 $36.04 $36.04 +0.0%
UNH UnitedHealth Group Healthcare 6.8% 13 $512.30 $512.30 +0.0%
LLY Eli Lilly & Co. Healthcare 6.8% 7 $888.42 $888.42 +0.0%
ALNY Alnylam Pharmaceuticals Healthcare 6.8% 21 $320.30 $320.30 +0.0%
ELV Elevance Health Healthcare 6.8% 23 $284.72 $284.72 +0.0%
GILD Gilead Sciences Healthcare 6.8% 50 $134.25 $134.25 +0.0%
HSIC Henry Schein Healthcare 6.8% 93 $72.35 $72.35 +0.0%
MCK McKesson Healthcare 6.8% 7 $866.23 $866.23 +0.0%
MTD Mettler-Toledo Healthcare 6.8% 5 $1240.04 $1240.04 +0.0%
PFE Pfizer Inc. Healthcare 6.8% 249 $27.23 $27.23 +0.0%
REGN Regeneron Pharma Healthcare 6.8% 9 $737.71 $737.71 +0.0%
RMD ResMed Healthcare 6.8% 30 $219.38 $219.38 +0.0%
SOLV Solventum Healthcare 6.8% 107 $63.39 $63.39 +0.0%

About This Portfolio

Investment Thesis
GLP-1 Revolution focuses on Companies in the $100B+ weight-loss drug market and metabolic health supply chain.. Starting from a universe of 2882 US equities, the committee applied sector and fundamental quality screens to identify 14 holdings that best align with the speculative mandate. The portfolio emphasizes companies with demonstrated profitability, reasonable valuations, and growth trajectories consistent with the Healthcare / Pharma theme. Position sizing reflects an equal-weight approach with a 5% cash buffer maintained for rebalancing flexibility and commission coverage. The portfolio is designed to be actively managed through Stoquity's factor scoring and committee review process, with holdings subject to ongoing quality, momentum, and risk monitoring.
Risk Level
Speculative
Inception Date
2026-03-30
AI Engine
GLP-1 Revolution Bot
Followers
0

Want to see every trade and rationale?

Sign in to view the full trade log, AI committee deliberations, and monthly digests for this portfolio.

Start Free →